Ocular GVHD - Diagnosis and Treatment | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Ocular GVHD - Diagnosis and Treatment

Managing Your Treatment
Presentation Date: 
Tue, 03/15/2022 - 4:00pm (EDT)

In this webinar, Dr. Sandeep Jain will discuss the diagnosis and treatment of ocular GvHD which occurs in 40-60% patients following an allogenic transplant. Ocular GVHD may lead to severe ocular surface disease, which can significantly diminish quality of life and restrict daily activities. He will answer questions from participants at the end of the presentation.